MedPath

Methocarbamol

Methocarbamol Tablets 750mg

Approved
Approval ID

a88a6c84-b55a-4b6b-ac01-554079f6e304

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2022

Manufacturers
FDA

Key Therapeutics

DUNS: 080318791

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methocarbamol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70868-901
Application NumberANDA040489
Product Classification
M
Marketing Category
C73584
G
Generic Name
methocarbamol
Product Specifications
Route of AdministrationORAL
Effective DateMarch 31, 2022
FDA Product Classification

INGREDIENTS (8)

MethocarbamolActive
Quantity: 750 mg in 1 1
Code: 125OD7737X
Classification: ACTIB
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Starch, CornInactive
Code: O8232NY3SJ
Classification: IACT
Povidone K90Inactive
Code: RDH86HJV5Z
Classification: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Stearic AcidInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methocarbamol - FDA Drug Approval Details